Pediatric AML: Clinical Trials

1 trial for Pediatric AML, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow Pediatric AML: new trials by email Literature Review of Pediatric AML trials Research Report on Pediatric AML

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100)
PEG- BCT-100 - Cancer, Pediatric Solid Tumor
Phase 1 / Phase 2CompletedUniversity of Birmingham492018-08-282022-09-02

Narrower conditions

Neoplasms (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Leukemia (1)  ·  Leukemia, Lymphoid (1)  ·  Lymphatic Diseases (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms by Histologic Type (1)

Interventions

BCT-100 (1)

Sponsors

University of Birmingham (1)

Countries

Australia (1)  ·  Netherlands (1)  ·  United Kingdom (1)

Top investigators

Francis J Mussai, DPhil (1)

Results publications

PMID 38357205